Vika Wirdhani
Hemodialysis Unit, Dr. Sitanala General Hospital, Tangerang, Indonesia

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Venoplasty as a key solution for improving dialysis access: a literature review Ronald Winardi Kartika; Robiyatun; Nuly Juariah Mahnulia; Vika Wirdhani; Iskandar; Egi Wigia Kurniahayati; Edi Supriadi; Sarwoko; Eka Dian; Florentina Endah
Journal of Indonesia Vascular Access Vol. 6 No. 1 (2026): Available online : 1 June 2026
Publisher : Indonesian Vascular Access Association (IVAA)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51559/jinava.v6i1.92

Abstract

Background: Chronic kidney disease necessitates effective dialysis, which relies heavily on the integrity and patency of vascular access. Venoplasty has emerged as a pivotal intervention for maintaining this access. This literature review aims to evaluate venoplasty as a key solution for improving dialysis access. Methods: This literature review evaluates the mechanisms, indications, clinical outcomes, and procedural efficacy of venoplasty. A comprehensive literature search was conducted for randomized controlled trials and observational studies from the last decade, focusing on success rates, adverse events, and long-term patency. Results: Venoplasty, utilizing balloon catheters to dilate stenosed veins, demonstrates a success rate of 70–90% in restoring blood flow. This significantly reduces dialysis-related complications and hospitalizations. However, the risk of re-stenosis persists, often necessitating repeat interventions or alternative strategies like stenting in recurrent cases. Conclusion: Venoplasty remains a cornerstone for managing central venous obstruction in dialysis patients, significantly improving quality of life and reducing intervention frequency. As chronic kidney disease prevalence rises, integrating venoplasty into standard care is essential. Future research should prioritize advanced techniques, such as drug-coated balloons, to enhance durability and address current limitations in treating vascular access failure.